Matthew I. Gibson

Professor Matthew I. Gibson holds a joint appointment between the University of Warwick's Department of Chemistry and Warwick Medical School. A Royal Society Industry Research Fellow and ERC Consolidator Grant recipient, he leads the iCASE Scheme at the MRC-funded Doctoral Training Center and co-founded CryoLogyx Ltd.

• Education
  • MChem, 1st Class (2003), University of Durham
  • PhD in Macromolecular Chemistry (2007), University of Durham
  • Postdoc, EPFL (2007-2009)

Research focuses on glycosciences and biomaterials for cryopreservation, infection detection, and cell surface modification. His group develops glycosylated nanomaterials and ice recrystallization inhibitors with applications in cell therapy storage and diagnostics. Current projects include the EU-funded Nanocarb and ICE_PACK (ERC) initiatives.

Selected Publications address glycomaterial selectivity (2021, JACS Au), polymer-enhanced ice control (2021, JACS), cyclic ice-binding peptides (2021, Nature), and glycosylated nanoparticle diagnostics (2022, Chemical Society Reviews). Key keywords: Glycobiology, Biomimetic Materials, Polymer Nanotechnology, Antifreeze Proteins

Scientific Awards include the McBain Medal, RSC Emerging Technology Prize, and multiple Young Investigator recognitions from Biomacromolecules and MacroGroupUK.

Teaching includes modules on polymers, glycosciences, and living polymerization. He (co-)supervises 15+ PhD students in glyconanomaterials, cryoprotectants, and cell engineering projects.